Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 76420-895

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 76420-895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
Chemical structure diagram of Cyclobenzaprine Hydrochloride, showing its molecular framework with a tricyclic core and associated side chain containing nitrogen and methyl groups, accompanied by hydrochloride (HCl).*
FDA Label Image

Image (Image 2)

Image (Image 2)
An illustration of a spoon holding a mound of powder or granules. The drawing is simple, black and white, and outlines the spoon and the contents on it.*
FDA Label Image

Image (Image 3)

Image (Image 3)
An instructional illustration showing a hand holding a capsule with a band labeled "TOP." The image demonstrates the correct orientation for handling or administering the capsule.*
FDA Label Image

Image (Image 4)

FDA Label Image

Image (Image 5)

Image (Image 5)
An instructional illustration showing a hand opening a capsule and pouring the small beads from the capsule onto a spoon. This suggests a method to administer the capsule contents, likely for Cyclobenzaprine Hydrochloride extended-release capsules.*
FDA Label Image

Image (Image 6)

Image (Image 6)
A black-and-white line drawing of a person holding a spoon close to their mouth, illustrating the action of taking oral medication.*
FDA Label Image

Image (Image 7)

Image (Image 7)
An illustration showing a person drinking from a glass, demonstrating oral administration of a medication.*
FDA Label Image

15 mg Label (Image 8)

15 mg Label (Image 8)
Packaging labels for Cyclobenzaprine Hydrochloride ER Capsules USP 15 mg by Enovachem Pharmaceuticals include multiple versions for quantities of 30, 60, 90, and 100 capsules. Each label states the product is dark orange opaque capsules, manufactured by TWi Pharmaceuticals USA, Inc., with storage instructions and federal dispensing warnings.*
FDA Label Image

30mg Label (Image 9)

30mg Label (Image 9)
Packaging labels for Cyclobenzaprine Hydrochloride extended-release capsules, USP 30 mg, from Enovachem Pharmaceuticals. The labels show three package sizes: 30, 90, and 100 capsules. Each label includes NDC numbers, barcodes, manufacturing details by TWi Pharmaceuticals USA, Inc., and storage instructions. The capsule descriptions include white opaque and orange opaque body variations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.